1-6 of 6
Ralph A. Reisfeld
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Free
Amy K. Erbe, Wei Wang, Lakeesha Carmichael, KyungMann Kim, Eneida A. Mendonça, Yiqiang Song, Dustin Hess, Patrick K. Reville, Wendy B. London, Arlene Naranjo, Jacquelyn A. Hank, Mitchell B. Diccianni, Ralph A. Reisfeld, Stephen D. Gillies, Katherine K. Matthay, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Julie R. Park, M. Fevzi Ozkaynak, Andrew L. Gilman, Alice L. Yu, Paul M. Sondel
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (1): 189–196.
https://doi.org/10.1158/1078-0432.CCR-17-1767
Published: 02 January 2018
View articletitled, Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
Open the PDF for Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group in another window
Includes: Supplementary data
Journal Articles

A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children's Oncology Group

Free
Kaci L. Osenga, Jacquelyn A. Hank, Mark R. Albertini, Jacek Gan, Adam G. Sternberg, Jens Eickhoff, Robert C. Seeger, Katherine K. Matthay, C. Patrick Reynolds, Clare Twist, Mark Krailo, Peter C. Adamson, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sondel
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (6): 1750–1759.
https://doi.org/10.1158/1078-0432.CCR-05-2000
Published: 21 March 2006
View articletitled, A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children's Oncology Group
Open the PDF for A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children's Oncology Group in another window
Journal Articles

Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy

Free
Amir Abdollahi, David W. Griggs, Heike Zieher, Alexandra Roth, Kenneth E. Lipson, Rainer Saffrich, Hermann-Josef Gröne, Dennis E. Hallahan, Ralph A. Reisfeld, Juergen Debus, Andreas G. Niethammer, Peter E. Huber
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (17): 6270–6279.
https://doi.org/10.1158/1078-0432.CCR-04-1223
Published: 06 September 2005
View articletitled, Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy
Open the PDF for Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy in another window
Journal Articles

Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy

Free
Zane C. Neal, Jeannie C. Yang, Alexander L. Rakhmilevich, Ilia N. Buhtoiarov, Hillary E. Lum, Michael Imboden, Jacquelyn A. Hank, Holger N. Lode, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sondel
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4839–4847.
https://doi.org/10.1158/1078-0432.CCR-03-0799
Published: 21 July 2004
View articletitled, Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy
Open the PDF for Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy in another window
Journal Articles

Protective Immunity against Human Carcinoembryonic Antigen (CEA) Induced by an Oral DNA Vaccine in CEA-transgenic Mice

Free
Rong Xiang, Steve Silletti, Holger N. Lode, Carrie S. Dolman, J. Michael Ruehlmann, Andreas G. Niethammer, Ursula Pertl, Stephen D. Gillies, F. James Primus, Ralph A. Reisfeld
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (3): 856s–864s.
Published: 01 March 2001
View articletitled, Protective Immunity against Human Carcinoembryonic Antigen (CEA) Induced by an Oral DNA Vaccine in CEA-transgenic Mice
Open the PDF for Protective Immunity against Human Carcinoembryonic Antigen (CEA) Induced by an Oral DNA Vaccine in CEA-transgenic Mice in another window
Journal Articles

The Ch14.18-GM-CSF Fusion Protein Is Effective at Mediating Antibody-dependent Cellular Cytotoxicity and Complement-dependent Cytotoxicity in Vitro

Free
Ayse Batova, Arvid Kamps, Stephen D. Gillies, Ralph A. Reisfeld, Alice L. Yu
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 4259–4263.
Published: 01 December 1999
View articletitled, The Ch14.18-GM-CSF Fusion Protein Is Effective at Mediating Antibody-dependent Cellular Cytotoxicity and Complement-dependent Cytotoxicity in Vitro
Open the PDF for The Ch14.18-GM-CSF Fusion Protein Is Effective at Mediating Antibody-dependent Cellular Cytotoxicity and Complement-dependent Cytotoxicity in Vitro in another window